Danaher Stock
Danaher Corporation
Company data
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- United States
- CEO
- Julie Sawyer Montgomery
- Employees
- 59,000
- Market cap
- $161 B
- IPO
- 29/12/1978
Danaher Corporation is a diversified global technology and science company specializing in the development, manufacturing, and distribution of professional, medical, industrial, and commercial products and services. Established in 1969 as Diversified Mortgage Investors, Inc., the company officially rebranded as…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Danaher stock: price history
1D
-1.1%
1W
+4.2%
1M
+9.9%
6M
+17.6%
YTD
+0.1%
1Y
+8.6%
2Y
-14.5%
5Y
-14.3%
10Y
+239.3%
Next earnings date
Next earnings date
21/10/2026 (in 4 days)
Volatility around earnings
~80% stronger price swings than usual
Danaher stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Ask the agents about Danaher
Analyst assessment of Danaher
PRICE TARGET LOW
US$195.00
CONSENSUS
US$231.08
MEDIAN
US$240.00
PRICE TARGET HIGH
US$250.00
1
STRONG BUY
29
BUY
12
HOLD
1
SELL
0
STRONG SELL
43
TOTAL · Buy
As of: 13/10/2026
Danaher stock metrics
P/E
40.54
P/B
3.07
EV/EBITDA
24.16
RETURN ON EQUITY
1.7%
NET MARGIN
13.9%
DEBT/EQUITY
0.51
DIVIDEND YIELD
0.7%
AS OF
26/06/2026
Free float & liquidity
FREE FLOAT
89.0%
FLOAT SHARES
625,854,424
AVG. DAILY VOLUME (30D)
4,304,489
Insider transactions (SEC)
RALES MITCHELL P
RALES STEVEN M
Blair Rainer
Blair Rainer
Blair Rainer
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -1.1%
Forums (Reddit)
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about Danaher stock
What does Danaher do?
Danaher Corporation is a company in the Healthcare sector, Medical - Diagnostics & Research industry, headquartered in United States.
The CEO is Julie Sawyer Montgomery, the company employs around 59,000 people.
The IPO was on 29/12/1978; the stock trades on NYSE under the ticker DHR.
What do analysts say about Danaher stock?
43 analysts rate the stock, the consensus is Buy (as of 13/10/2026).
The average price target is US$231.08, ranging from US$195.00 to US$250.00, with a median of US$240.00.
This is an external assessment, not a statement by Market Jury.
When does Danaher report next?
The next earnings date is 21/10/2026.
Around past earnings, price swings were roughly 80% stronger than usual.
Does Danaher pay a dividend?
Yes. The last dividend was US$0.40 per share, ex-date 30/09/2026, paid on 30/10/2026.
The dividend yield is 0.7% (as of 26/06/2026).
Which stocks are comparable to Danaher?
Comparable stocks include Thermo Fisher Scientific, Natera, Agilent Technologies, IQVIA Holdings, Waters, Illumina, IDEXX Laboratories and Mettler-Toledo International.
How can I get Danaher stock analyzed?
Clicking "Analyze stock" lets five strategies assess Danaher against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.